High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers

Paula Vainio, Laura Lehtinen, Mika Hilvo, T. Mirtti, John Mpindi, Pekka Kohonen, Vidal Fey, Kirsi Ketola, K. Alanen, Merja Perälä, Matej Oresic, Olli Kallioniemi, Kristiina Iljin

Research output: Contribution to conferenceConference articleScientific

Original languageEnglish
Publication statusPublished - 2010
MoE publication typeNot Eligible
EventInsights in Cancer Progression and Invasion - Helsinki, Finland
Duration: 3 Jun 20104 Jun 2010

Conference

ConferenceInsights in Cancer Progression and Invasion
CountryFinland
CityHelsinki
Period3/06/104/06/10

Cite this

Vainio, P., Lehtinen, L., Hilvo, M., Mirtti, T., Mpindi, J., Kohonen, P., ... Iljin, K. (2010). High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers. Paper presented at Insights in Cancer Progression and Invasion, Helsinki, Finland.
Vainio, Paula ; Lehtinen, Laura ; Hilvo, Mika ; Mirtti, T. ; Mpindi, John ; Kohonen, Pekka ; Fey, Vidal ; Ketola, Kirsi ; Alanen, K. ; Perälä, Merja ; Oresic, Matej ; Kallioniemi, Olli ; Iljin, Kristiina. / High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers. Paper presented at Insights in Cancer Progression and Invasion, Helsinki, Finland.
@conference{f80512850d554fe19a712598d75cf802,
title = "High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers",
author = "Paula Vainio and Laura Lehtinen and Mika Hilvo and T. Mirtti and John Mpindi and Pekka Kohonen and Vidal Fey and Kirsi Ketola and K. Alanen and Merja Per{\"a}l{\"a} and Matej Oresic and Olli Kallioniemi and Kristiina Iljin",
year = "2010",
language = "English",
note = "Insights in Cancer Progression and Invasion ; Conference date: 03-06-2010 Through 04-06-2010",

}

Vainio, P, Lehtinen, L, Hilvo, M, Mirtti, T, Mpindi, J, Kohonen, P, Fey, V, Ketola, K, Alanen, K, Perälä, M, Oresic, M, Kallioniemi, O & Iljin, K 2010, 'High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers' Paper presented at Insights in Cancer Progression and Invasion, Helsinki, Finland, 3/06/10 - 4/06/10, .

High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers. / Vainio, Paula; Lehtinen, Laura; Hilvo, Mika; Mirtti, T.; Mpindi, John; Kohonen, Pekka; Fey, Vidal; Ketola, Kirsi; Alanen, K.; Perälä, Merja; Oresic, Matej; Kallioniemi, Olli; Iljin, Kristiina.

2010. Paper presented at Insights in Cancer Progression and Invasion, Helsinki, Finland.

Research output: Contribution to conferenceConference articleScientific

TY - CONF

T1 - High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers

AU - Vainio, Paula

AU - Lehtinen, Laura

AU - Hilvo, Mika

AU - Mirtti, T.

AU - Mpindi, John

AU - Kohonen, Pekka

AU - Fey, Vidal

AU - Ketola, Kirsi

AU - Alanen, K.

AU - Perälä, Merja

AU - Oresic, Matej

AU - Kallioniemi, Olli

AU - Iljin, Kristiina

PY - 2010

Y1 - 2010

M3 - Conference article

ER -

Vainio P, Lehtinen L, Hilvo M, Mirtti T, Mpindi J, Kohonen P et al. High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers. 2010. Paper presented at Insights in Cancer Progression and Invasion, Helsinki, Finland.